Cargando…

Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations

Background: Triple-negative breast cancers (TNBC) are characterized by aggressive tumour biology resulting in a poor prognosis. Androgen receptor (AR) is one of newly emerging biomarker in TNBC. In recent years, ARs have been demonstrated to play an important role in the genesis and in the developme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pistelli, Mirco, Caramanti, Miriam, Biscotti, Tommasina, Santinelli, Alfredo, Pagliacci, Alessandra, De Lisa, Mariagrazia, Ballatore, Zelmira, Ridolfi, Francesca, Maccaroni, Elena, Bracci, Raffaella, Berardi, Rossana, Battelli, Nicola, Cascinu, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190544/ https://www.ncbi.nlm.nih.gov/pubmed/24978437 http://dx.doi.org/10.3390/cancers6031351

Ejemplares similares

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
por: Pistelli, Mirco, et al.
Publicado: (2015)

Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex
por: Berardi, Rossana, et al.
Publicado: (2016)

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
por: De Lisa, Mariagrazia, et al.
Publicado: (2020)

Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report
por: Ballatore, Z., et al.
Publicado: (2016)

Role of maspin in cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Correction to: Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
por: Berardi, Rossana, et al.
Publicado: (2010)

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials
por: Berardi, Rossana, et al.
Publicado: (2016)

New Insights into Hormonal Therapies in Uterine Sarcomas
por: Maccaroni, Elena, et al.
Publicado: (2022)

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy
por: Berardi, Rossana, et al.
Publicado: (2015)

Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2020)

A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2023)

Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis
por: Ramadori, Giorgio, et al.
Publicado: (2015)

Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis
por: Scartozzi, Mario, et al.
Publicado: (2009)

Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
por: Agostinelli, Veronica, et al.
Publicado: (2023)

Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type
por: Maccaroni, Elena, et al.
Publicado: (2021)

Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?
por: Maccaroni, Elena, et al.
Publicado: (2015)

The Impact of Lifestyle Interventions in High-Risk Early Breast Cancer Patients: A Modeling Approach from a Single Institution Experience
por: Pistelli, Mirco, et al.
Publicado: (2021)

Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context
por: Moroncini, Gianluca, et al.
Publicado: (2018)

Somatostatin analogs: is one better than other?
por: Rossana, Berardi, et al.
Publicado: (2017)

Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine
por: Ballatore, Zelmira, et al.
Publicado: (2023)

Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience
por: Pistelli, Mirco, et al.
Publicado: (2021)

A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study
por: Natalucci, Valentina, et al.
Publicado: (2021)

Optimal management of resected gastric cancer
por: Giampieri, Riccardo, et al.
Publicado: (2018)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2017)

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis
por: Bittoni, Alessandro, et al.
Publicado: (2015)

Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study
por: Berardi, Rossana, et al.
Publicado: (2020)

Cancer patient perspective in the arena of COVID‐19 pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2021)

Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis
por: Giampieri, Riccardo, et al.
Publicado: (2017)

Primum non Nocere: How to ensure continuity of care and prevent cancer patients from being overlooked during the COVID‐ 19 pandemic
por: Agostinelli, Veronica, et al.
Publicado: (2022)

[(11)C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas
por: Santoni, Matteo, et al.
Publicado: (2014)

BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
por: Maccaroni, Elena, et al.
Publicado: (2021)

Immunohistochemical Expression and Localization of Somatostatin Receptor Subtypes in Androgen Ablated Prostate Cancer
por: Mazzucchelli, Roberta, et al.
Publicado: (2010)

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
por: Conti, Alessandro, et al.
Publicado: (2013)

SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
por: Giugliano, Federica, et al.
Publicado: (2022)

Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer
por: Khadela, Avinash, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l39g99e6phm4cq9phfi8rbbnvl